Xi'an Ebatter Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xi'an Ebatter Biotechnology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 29 (Meats & Processed Foods) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EASTBART. The owner is based in Development Zone,Xi'an.

Rm.501-505,Block B,Saigao St.,Fengcheng

5th Rd., Xi'an Economic & Technological

Development Zone,Xi'an 710000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Xi'an Ebatter Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

29
Meats & Processed Foods (2 filings)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

Frequently Asked Questions

How many trademarks does Xi'an Ebatter Biotechnology Co., Ltd. have?

Xi'an Ebatter Biotechnology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Xi'an Ebatter Biotechnology Co., Ltd. file in?

Xi'an Ebatter Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 29 (Meats & Processed Foods). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.

What are Xi'an Ebatter Biotechnology Co., Ltd.'s most well-known trademarks?

Xi'an Ebatter Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as EASTBART. These are among 1 currently registered trademark in the portfolio.

What is Xi'an Ebatter Biotechnology Co., Ltd.'s trademark registration success rate?

Xi'an Ebatter Biotechnology Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.